Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 7/2017

01-07-2017 | Letter to the Editor

Successful treatment with bendamustine and rituximab for paraneoplastic pemphigus

Authors: Taku Kikuchi, Takehiko Mori, Takayuki Shimizu, Yuya Koda, Ryohei Abe, Yuichi Kurihara, Takeru Funakoshi, Jun Yamagami, Hidekazu Sato, Kazuyuki Tsunoda, Masayuki Amagai, Shinichiro Okamoto

Published in: Annals of Hematology | Issue 7/2017

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Anhalt GJ, Kim SC, Stanley JR, Korman NJ, Jabs DA, Kory M, Izumi H, Ratrie H 3rd, Mutasim D, Ariss-Abdo L, Larib RS (1990) Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med 323:1729–1735CrossRefPubMed
2.
3.
Nishibori Y, Hashimoto T, Ishiko A, Shimizu H, Korman NJ, Nishikawa T (1995) Paraneoplastic pemphigus: the first case report from Japan. Dermatology 191:39–42CrossRefPubMed
4.
Stark GL, Goff DK, Spickett GP, Wojnarowska F, Langtry JA (2003) Paraneoplastic pemphigus occurring after radiotherapy for relapsed non-Hodgkin’s lymphoma in a patient with common variable immunodeficiency. Hematol J 4:154–158CrossRefPubMed
5.
Plumb R, Doolittle GC (1996) Paraneoplastic pemphigus in a patient with non-Hodgkin’s lymphoma. Am J Hematol 52:58–59CrossRefPubMed
6.
Anan T, Shimizu F, Hatano Y, Okamoto O, Katagiri K, Fujiwara S (2011) Paraneoplastic pemphigus associated with corneal perforation and cutaneous alternariosis: a case report and review of cases treated with rituximab. J Dermatol 38:1084–1089CrossRefPubMed
7.
Rummel M, Kaiser U, Balser C, Stauch M, Brugger W, Welslau M, Niederle N, Losem C, Boeck HP, Weidmann E, von Gruenhagen U, Mueller L, Sandherr M, Hahn L, Vereshchagina J, Kauff F, Blau W, Hinke A, Barth J; Study Group Indolent Lymphomas. Bendamustine plus rituximab versus fludarabine plus rituximab for patients with relapsed indolent and mantle-cell lymphomas: a multicentre, randomised, open-label, non-inferiority phase 3 trial. Lancet Oncol. 2016;17:57–66.
8.
Rummel MJ, Niederle N, Maschmeyer G, Banat GA, von Grünhagen U, Losem C, Kofahl-Krause D, Heil G, Welslau M, Balser C, Kaiser U, Weidmann E, Dürk H, Ballo H, Stauch M, Roller F, Barth J, Hoelzer D, Hinke A, Brugger W; Study group indolent Lymphomas (StiL). Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial. Lancet 2013;381:1203–1210.
9.
Higo T, Miyagaki T, Nakamura F, Shinohara A, Asano H, Abe H, Senda N, Yoshizaki A, Fukayama M, Kurokawa M (2015) Paraneoplastic pemphigus occurring after bendamustine and rituximab therapy for relapsed follicular lymphoma. Ann Hematol 94:683–685CrossRefPubMed
Metadata
Title
Successful treatment with bendamustine and rituximab for paraneoplastic pemphigus
Authors
Taku Kikuchi
Takehiko Mori
Takayuki Shimizu
Yuya Koda
Ryohei Abe
Yuichi Kurihara
Takeru Funakoshi
Jun Yamagami
Hidekazu Sato
Kazuyuki Tsunoda
Masayuki Amagai
Shinichiro Okamoto
Publication date
01-07-2017
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 7/2017
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-017-3008-8

Other articles of this Issue 7/2017

Annals of Hematology 7/2017 Go to the issue

Review Article

Advances in the treatment of relapsed/refractory chronic lymphocytic leukemia

Letter to the Editor

HbQ-India (HBA1:c.193G>C): hematological profiles and unique CE-HPLC findings of potential diagnostic utility in 65 cases

Erratum

Erratum to: Role of complexity of variant Philadelphia chromosome in chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy

Letter to the Editor

Low-dose nivolumab induced remission in refractory classical Hodgkin lymphoma

Review Article

Ibrutinib in CLL: a focus on adverse events, resistance, and novel approaches beyond ibrutinib

Letter to the Editor

Donor lymphocyte infusion reversed graft rejection in matched-unrelated donor hematopoietic stem cell transplantation for a child with thalassemia

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits